Table 1. Some medications tested in phase 3 clinical trials for NASH.

Medications	Conditions for treatment	Current status in phase III trials
Obeticholic acid	Fibrosis due to NASH	Active; not recruiting
Selonsertib	NASH and fibrosis	Terminated
Cenicriviroc	NASH	Terminated
Elafibranor	NASH with fibrosis	Terminated
Rimonabant	NASH without diabetes	Terminated
Pentoxifylline	NASH	Completed
Resmetirom	NASH and fibrosis	Recruiting

Data was retrieved from https://clinicaltrials.gov/ on February 16, 2021 by searching condition or disease and “nonalcoholic steatohepatitis.”